DEFSEC Technologies (NASDAQ:DFSC – Get Free Report) and Nukkleus (NASDAQ:DFNS – Get Free Report) are both small-cap industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, earnings, dividends and risk.
Earnings & Valuation
This table compares DEFSEC Technologies and Nukkleus”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DEFSEC Technologies | $3.53 million | 0.33 | -$6.88 million | ($4.62) | -0.13 |
| Nukkleus | N/A | N/A | $78.55 million | ($397.10) | -0.01 |
Nukkleus has lower revenue, but higher earnings than DEFSEC Technologies. DEFSEC Technologies is trading at a lower price-to-earnings ratio than Nukkleus, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings and target prices for DEFSEC Technologies and Nukkleus, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DEFSEC Technologies | 1 | 0 | 0 | 0 | 1.00 |
| Nukkleus | 1 | 0 | 0 | 1 | 2.50 |
Insider and Institutional Ownership
21.4% of DEFSEC Technologies shares are owned by institutional investors. Comparatively, 12.5% of Nukkleus shares are owned by institutional investors. 11.1% of Nukkleus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Profitability
This table compares DEFSEC Technologies and Nukkleus’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DEFSEC Technologies | -120.97% | -144.66% | -82.13% |
| Nukkleus | N/A | N/A | -26.92% |
Volatility and Risk
DEFSEC Technologies has a beta of 2.82, indicating that its stock price is 182% more volatile than the S&P 500. Comparatively, Nukkleus has a beta of -6.05, indicating that its stock price is 705% less volatile than the S&P 500.
Summary
Nukkleus beats DEFSEC Technologies on 8 of the 12 factors compared between the two stocks.
About DEFSEC Technologies
DEFSEC develops and commercializes breakthrough next-generation tactical systems for military and security forces. The Company’s current portfolio of offerings includes digitization of tactical forces for real-time shared situational awareness and targeting information from any source (including drones) streamed directly to users’ smart devices and weapons. Other DEFSEC products include countermeasures against threats such as electronic detection, lasers and drones. These systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems, and all come integrated with TAK. The Company also has a new proprietary non-lethal product line branded PARA OPSTM with applications across all segments of the non-lethal market, including law enforcement. The Company is headquartered in Ottawa, Canada, with representative offices in London, UK and Abu Dhabi, UAE.
About Nukkleus
Nukkleus Inc., a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions. Nukkleus Inc. was founded in 2013 and is headquartered in Jersey City, New Jersey.
Receive News & Ratings for DEFSEC Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DEFSEC Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
